Human leukocyte antigen alleles associate with COVID-19 vaccine immunogenicity and risk of breakthrough infection

Oxford COVID Vaccine Trial Genetics Study Team Group, Alexander J. Mentzer*, Daniel O'Connor, Sagida Bibi, Irina Chelysheva, Elizabeth A. Clutterbuck, Tesfaye Demissie, Tanya Dinesh, Nick J. Edwards, Sally Felle, Shuo Feng, Amy L. Flaxman, Eleanor Karp-Tatham, Grace Li, Xinxue Liu, Natalie Marchevsky, Leila Godfrey, Rebecca Makinson, Maireid B. Bull, Jamie FowlerBana Alamad, Tomas Malinauskas, Amanda Y. Chong, Katherine Sanders, Robert H. Shaw, Merryn Voysey, Matthew D. Snape, Andrew J. Pollard, Teresa Lambe, Julian C. Knight*

*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

50 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Human leukocyte antigen alleles associate with COVID-19 vaccine immunogenicity and risk of breakthrough infection'. Together they form a unique fingerprint.

Keyphrases

Immunology and Microbiology

Biochemistry, Genetics and Molecular Biology